BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 6, Issue 3
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Nephrology
ISSN
2220-6124
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review
©The Author(s) 2017.
World J Nephrol. May 6, 2017; 6(3): 86-99
Published online May 6, 2017. doi: 10.5527/wjn.v6.i3.86
Table 8 Experimental drugs and procedures to prevent contrast-induced acute kidney injury
Drugs
Hydration with isotonic saline[57-59]
N-acetyl-cysteine[69,106-110]
Sodium bicarbonate[58,68,108,109,111]
Theophylline[112-114]
Mannitol[115]
Furosemide[115-117]
Ascorbic acid (vitamin C)[118]
Tocopherol (vitamin E)[119]
Statins[120-124]
Mesna[125]
Dopamine[126]
Fenoldopam (dopamin agonist)[127]
Calcium channel blockers (verapamil, diltiazem)[128]
Adenosine[129]
Endothelin receptor antagonists[130]
Atrial natriuretic peptide[131]
Iloprost (PGI2 analogue)[132]
Misoprostol (PGE1 analogue)[133]
Trimetazidine[134]
Erythropoetin[135,136]
Nebivolol[137]
Sodium citrate[138]
Procedures
Remote ischemic preconditioning[72,73]
Prophylactic hemodialysis/hemofiltration/hemodiafiltration[71,139,140]
Full Size Table
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.